ATF6
前列腺癌
基因敲除
蛋白质稳态
未折叠蛋白反应
癌症研究
雄激素受体
转录组
生物
癌症
XBP1型
雄激素剥夺疗法
内质网
细胞
基因
医学
细胞生物学
基因表达
核糖核酸
遗传学
RNA剪接
作者
Hongqing Zhou,Tingting Zhang,Liang Chen,Fengzhen Cui,Chenxiang Xu,Jiaxi Peng,Wei‐Xiang Ma,Ji‐Rong Huang,Xia Sheng,Mingsheng Liu,Faming Zhao
标识
DOI:10.1096/fj.202201347r
摘要
Abstract Stress in the endoplasmic reticulum (ER) may perturb proteostasis and activates the unfolded protein response (UPR). UPR activation is frequently observed in cancer cells and is believed to fuel cancer progression. Here, we report that one of the three UPR sensors, ATF6α, was associated with prostate cancer (PCa) development, while both genetic and pharmacological inhibition of ATF6α impaired the survival of castration‐resistance PCa (CRPC) cells. Transcriptomic analyses identified the molecular pathways deregulated upon ATF6α depletion, and also discovered considerable disparity in global gene expression between ATF6α knockdown and Ceapin‐A7 treatment. In addition, combined analyses of human CRPC bulk RNA‐seq and single‐cell RNA‐seq (scRNA‐seq) public datasets confirmed that CRPC tumors with higher ATF6α activity displayed higher androgen receptor (AR) activity, proliferative and neuroendocrine (NE) like phenotypes, as well as immunosuppressive features. Lastly, we identified a 14‐gene set as ATF6α NE gene signature with encouraging prognostic power. In conclusion, our results indicate that ATF6α is correlated with PCa progression and is functionally relevant to CRPC cell survival. Both specificity and efficacy of ATF6α inhibitors require further refinement and evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI